Murphy Nicole (CIK 1910644) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-17). Recent activity: Buy BIIB (3 shares), Sell BIIB (914 shares), Buy BIIB (2,102 shares), Sell BIIB (1,017 shares), Buy BIIB (1,940 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-17 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Buy | 3 | $585 |
| 2026-02-10 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Sell | 914 | $183,879 |
| 2026-02-10 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Buy | 2,102 | $0 |
| 2026-02-10 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Sell | 1,017 | $204,600 |
| 2026-02-10 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Buy | 1,940 | $0 |
| 2026-02-10 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Buy | 4,683 | $0 |
| 2026-02-10 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Sell | 1,408 | $283,261 |
| 2025-02-12 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Buy | 2,272 | $0 |
| 2025-02-12 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Sell | 670 | $95,502 |
| 2025-02-10 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Buy | 2,102 | $0 |
| 2025-02-10 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Sell | 620 | $87,637 |
| 2025-02-10 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Buy | 1,940 | $0 |
| 2025-02-10 | BIOGEN INC. (BIIB) | Head of Pharm Ops and Tech | Sell | 603 | $85,234 |
Source: SEC Form 4 filings · as of 2026-02-17